Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis

American Journal on Mental Retardation

Volumn 109, Issue 4, 2004, Pages 310-321

  Zarcone, Jennifer R ^a,b,e   Lindauer, Steven E ^a,d   Morse, Paige S ^a   Crosland, Kimberly A ^a   Valdovinos, Maria G ^a,c   McKerchar, Todd L ^a   Reese, R Matthew ^b   Hellings, Jessica A ^b   Schroeder, Stephen R ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d KENNEDY KRIEGER INSTITUTE   (United States)

^e UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; RISPERIDONE; NEUROLEPTIC AGENT;

ATTENTION DEFICIT DISORDER; AUTOMUTILATION; BIOLOGICAL MODEL; CAREGIVER; CLINICAL TRIAL; DEVELOPMENTAL DISORDER; DRUG EFFECT; FUNCTIONAL ASSESSMENT; HEALTH PROGRAM; HUMAN; INSTRUMENTAL CONDITIONING; MEDICAL SCHOOL; NEUROBIOLOGY; REVIEW; ADULT; AGGRESSION; ARTICLE; CHILD; CONTROLLED CLINICAL TRIAL; FEMALE; MALE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGGRESSION; ANTIPSYCHOTIC AGENTS; CHILD; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS; RISPERIDONE; SELF-INJURIOUS BEHAVIOR;

EID: 5444260738     PISSN: 08958017     EISSN: None     Source Type: Journal    
DOI: 10.1352/0895-8017(2004)109<310:EORODB>2.0.CO;2     Document Type: Review

References (34)

1. Aman, M. G., Burrow, W. H., & Wolford, P. L. (1995). The Aberrant Behavior Checklist-Community: Factor validity and effect of subject variables for adults in group homes. American Journal on Mental Retardation, 100, 283-292.
2. Aman, M. G., De Smedt, G., Derivan, A., Lyons, B., & Findling, R. L. (2002). Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behavior disorders in children with subaverage intelligence. American Journal of Psychiatry, 159, 1337-1346.
3. Aman, M. G., & Madrid, A. (1999). Atypical antipsychotics in persons with developmental disabilities. Mental Retardation and Developmental Disabilities Research Reviews, 5, 253-263.
4. Aman, M. G., Sing, N. N., Stewart, A. W., & Field, C. J. (1985). Psychometric characteristics of the Aberrant Behavior Checklist. American Journal of Mental Deficiency, 89, 492-502.
5. Durand, V. M., & Crimmins, D. B. (1988). Identifying variables maintaining self-injurious behavior. Journal of Autism and Developmental Disorders, 18, 99-117.
6. Emerson, E., Thompson, S., Reeves, D., Henderson, D., & Robertson, J. (1995). Descriptive analysis of multiple response topographies of challenging behavior across two settings. Research in Developmental Disabilities, 16, 301-329.
7. Garcia, D., & Smith, R. G. (1999). Using analog baselines to assess the effects of naltrexone on self-injurious behavior. Research in Developmental Disabilities, 20, 1-21.
8. Gardner, W. I., Graeber, J. C., & Cole, C. L. (1996). Behavior therapies: A multi-modal diagnostic and intervention model. In J. Jacobson & J. A. Mulick (Eds.), Manual of diagnosis and professional practice in mental retardation (pp. 355-370). Washington, DC: American Psychological Association.
9. Guy, W. (1976). Assessment manual for psychopharmacology. Washington, DC: U.S. Government Printing Office.
10. Hellings, J. A., Zarcone, J. R., Crandall, K., Wallace, D., & Schroeder, S. R. (2001). Weight gain in a controlled study of risperidone in children: Adolescents and adults with mental retardation and autism. Journal of Child and Adolescent Psychopharmacology, 11, 229-238.
11. Iwata, B. A., Dorsey, M. F., Slifer, K. J., Bauman, K. E., & Richman, G. S. (1994). Toward a functional analysis of self-injury. Journal of Applied Behavior Analysis, 27, 197-209
12. (Reprinted from Analysis and Intervention in Developmental Disabilities, 2, 3-20, 1982).
13. Kennedy, C. H., & Meyer, K. A. (1996). Sleep deprivation, allergy symptoms, and negatively reinforced problem behavior. Journal of Applied Behavior Analysis, 29, 133-135.
14. Luiselli, J. K. (1986). Behavior analysis of pharmacological and contingency management interventions for self-injury. Journal of Behavior Therapy and Experimental Psychiatry, 17, 275-284.
15. Mace, F. C., & Mauk, J. E. (1995). Bio-behavioral diagnosis and treatment of self-injury. Mental Retardation and Developmental Disabilities Research Reviews, 1, 104-110.
16. McDougle, C. J., Holmes, J. P., Carlson, D. C., Pelton, G. H., Cohen, D. J., & Price, L. H. (1998). A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Archives of General Psychiatry, 55, 633-641.
17. Michael, J. (1982). Discriminating between discriminant and motivational functions of stimuli. Journal of the Experimental Analysis of Behavior, 37, 149-155.
18. Michael, J. (1993). Establishing operations. Behavior Analyst, 1, 191-206.
19. Northup, J., Fusilier, I., Swanson, V., Huete, J., Bruce, T., Freeland, J., Gulley, V., & Edwards, S. (1999). Further analysis of the separate and interactive effects of methylphenidate and common classroom contingencies. Journal of Applied Behavior Analysis, 32, 35-50.
20. Northup, J., Fusilier, I., Swanson, V., Roane, H., & Borrero, J. (1997). An evaluation of methylphenidate as a potential establishing operation for some common classroom reinforcers. Journal of Applied Behavior Analysis, 30, 614-626.
21. Northup, J., Jones, K., Broussard, C., DiGiovanni, G., Herring, M., Fusilier, I., & Hanchey, A. (1997). A preliminary analysis of interactive effects between common classroom contingencies and MPH. Journal of Applied Behavior Analysis, 30, 121-125.
22. O'Neill, R. E., Horner, R. H., Albin, R. W., Sprague, J. R., Storey, K., & Newton, J. S. (1997). Functional assessment and program development for problem behavior: A practical handbook (2nd ed.). Pacific Grove, CA: Brooks/Cole.
23. O'Reilly, M. F. (1995). Functional analysis and treatment of escape-maintained aggression correlated with sleep deprivation. Journal of Applied Behavior Analysis, 28, 225-226.
24. O'Reilly, M. F. (1997). Functional analysis of episodic self-injury correlated with recurrent otitis media. Journal of Applied Behavior Analysis, 30, 165-167.
25. Reese, R. M., Hellings, J. A., & Schroeder, S. R. (1999). Treatment methods for destructive and aggressive behaviour in people with severe mental retardation/developmental disabilities. In N. Bouras (Ed.), Psychiatric and behavioural disorders with severe mental retardation/developmental disabilities (pp. 249-261). London: Cambridge University Press.
26. Research Units on Pediatric Psychopharmacology Autism Network. (2002). Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347, 314-321.
27. Sandman, C. A., Thompson, T., Barret, R. P., Verhoeven, W. M. A., McCubbin, J. A., Schroeder, S. R., & Hetrick, W. P. (1998). Opiate blockers. In S. Reiss & M. G. Aman (Eds.), The international consensus handbook on psychopharmacology (pp. 291-302). Columbus: The Ohio State University, Nisonger Center.
28. Schaal, D. W., & Hackenberg, T. (1994). Toward a functional analysis of drug treatment for behavior problems of people with developmental disabilities. American Journal on Mental Retardation, 99, 123-140.
29. Snyder, R., Turgay, A., Aman, M., Binder, C., Fisman, S., & Carroll, A. (2002). Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQ's. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1026-1036.
30. Symons, F. J., Tapp, J., Wulfsberg, A., Sutton, K. A., Heeth, W. L., & Bodfish, J. W. (2001). Sequential analysis of the effects of naltrexone on the environmental mediation of self-injurious behavior. Experimental Clinical Psychopharmacology, 3, 269-276.
31. Thompson, T., Egli, M., Symons, F., & Delaney, D. (1994). Neurobehavioral mechanisms of drug action in developmental disabilities. In T. Thompson & D. B. Gray (Eds.), Destructive behavior in developmental disabilities: Diagnosis and treatment (pp. 133-188). Thousand Oaks, CA: Sage.
32. Valdovinos, M. G., Napolitano, D. A., Zarcone, J. R., Hellings, J. A., Williams, D. C., & Schroeder, S. R. (2002). Multimodal evaluation of risperidone for destructive behavior: Functional analysis, direct observations, rating scales, and psychiatric impressions. Experimental and Clinical Psychopharmacology, 10, 268-275.
33. Yoder, P., & Feurer, I. (2000). Quantifying the magnitude of sequential association between events and behaviors. In T. Thompson, D. Felce, & F. Symons (Eds.), Behavioral observation: Technology and applications in developmental disabilities (pp. 317-334). Baltimore: Brookes.
34. Zarcone, J. R., Hellings, J. A., Crandall, K., Reese, R. M., Marquis, J., Fleming, K., Shores, R., Williams, D., & Schroeder, S. R. (2001). Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures. American Journal on Mental Retardation, 106, 525-538.